Urology · Atlanta, GA
NPI
1598990533
Since 2009
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
371 E Paces Ferry Road, Suite 550
Atlanta, GA, 30305
Phone (404) 400-3120
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
1,268 services
Medicare patients, 2024
141
Average age 69
Drug cost, 2024
$404K
1,530 prescriptions
Company payments, 2025
$3,448
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tariq S Hakky was code 99213 (office e&m - established), 169 times for 102 patients. In total Tariq S Hakky billed 1,268 services in 82 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 169 | 102 | $56.87 | $9,612 |
| 99214 Office E&M - Established | Office | 147 | 85 | $85.08 | $13K |
| 81003 Clinical Chemistry | Office | 121 | 53 | $2.20 | $266 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 83 | 58 | $77.41 | $6,425 |
| 76870 Ultrasound - Nonspecific | Office | 72 | 41 | $69.37 | $4,995 |
| 51798 Ultrasound - Nonspecific | Office | 47 | 29 | $8.07 | $379 |
| 93980 Duplex Scan - Extremity Arteries | Office | 36 | 28 | $80.24 | $2,889 |
| 93975 Duplex Scan - Extremity Arteries | Office | 32 | 18 | $189.60 | $6,067 |
| 99204 Office E&M - New | Office | 24 | 24 | $91.72 | $2,201 |
| 52000 Cystourethroscopy | Office | 21 | 17 | $168.56 | $3,540 |
| 54405 Other Organ Systems | Facility | 19 | 19 | $596.62 | $11K |
| 93000 Electrocardiogram | Office | 17 | 15 | $10.07 | $171 |
| 99203 Office E&M - New | Office | 16 | 16 | $59.65 | $954 |
| 51741 Test - Miscellaneous | Office | 16 | 14 | $6.70 | $107 |
| 51726 Other Organ Systems | Office | 13 | 12 | $218.53 | $2,841 |
By year: 2022 $86K for 872 services; 2023 $92K for 1,096 services; 2024 $93K for 1,268 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 121 | 53 | $2.20 | $266 |
Medicare prescription drug claims, 2024
In 2024, the drug Tariq S Hakky prescribed most often to Medicare patients was Tamsulosin Hcl, with 120 prescriptions and refills. In total Tariq S Hakky wrote 1,530 Medicare prescriptions that cost $404K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 120 | 336 | 39 | $1,295 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 102 | 102 | 56 | $425 |
| Cabergoline Generic | 97 | 234 | 38 | $10K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 91 | 91 | 53 | $130 |
| Solifenacin Succinate Generic | 80 | 182 | 37 | $3,853 |
| Finasteride Generic | 74 | 201 | 24 | $607 |
| Gabapentin Generic | 67 | 76 | 37 | $218 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 63 | 179 | 23 | $1,047 |
| Ciprofloxacin Hcl Generic | 61 | 61 | 33 | $186 |
| Testosterone Cypionate Generic | 61 | 128 | 23 | $3,673 |
| Cephalexin Generic | 58 | 58 | 38 | $841 |
| Xyosted Testosterone Enanthate | 56 | 56 | Under 11 | $34K |
| Doxycycline Hyclate Generic | 50 | 50 | 23 | $283 |
| Fluconazole Generic | 38 | 38 | 19 | $228 |
| Myrbetriq Mirabegron | 35 | 45 | Under 11 | $20K |
Brand drugs: - claims; generic drugs: 1,334 claims; opioid claims: 140.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tariq S Hakky $3,448 ($3,448 in general payments such as food, travel and fees) from 15 companies. The largest payer was Coloplast Corp with $1,629.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.